It is especially difficult within the life sciences sector – and indeed everyday life – to avoid mentions of AI and the inevitable changes it will bring, and is bringing, to drug discovery.   Further difficulty stems from the need to distinguish between hype, reality and fantasy. Drug discovery and development is a slow and costly process, where […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!